GLOW50 (GHK-Cu + TB-500 + BPC-157)
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
GLOW50 is a three-component research blend containing 35 mg GHK-Cu, 10 mg TB-500 and 5 mg BPC-157 per vial, totaling 50 mg. Each box contains 10 vials. It has a different composition from BBG50, which contains 50 mg GHK-Cu, 10 mg TB-500 and 10 mg BPC-157 per vial.
No published certificates yet.
SKU et conditionnement
| SKU | Par flacon | Flacons par boîte | Prix de la boîte |
|---|---|---|---|
| GLOW50 | 50 mg | 10 | 119,00Â $US |
Les quantités nominales correspondent à l’étiquette ; les mesures figurent dans chaque rapport de lot. Un rapport publié ne confirme pas le lot d’une future commande.
Questions sur le produit et ses documents
Comment lire la quantité et le conditionnement ?
La quantité par flacon et le nombre de flacons sont indiqués séparément dans le tableau. Le prix correspond à une boîte. Pour un mélange, la quantité peut être totale ; consultez l’étiquette et le rapport pour chaque composant.
Comment trouver le COA correspondant ?
Vérifiez le produit, le SKU et le numéro de lot. La page du lot contient les résultats, le rapport original et le lien de vérification. Contactez le support si le lot attribué n’est pas indiqué sur votre commande.
Une valeur de pureté signifie-t-elle que tous les tests sont conformes ?
Non. Identité, pureté, remplissage et endotoxines sont des mesures distinctes. Consultez chaque résultat et unité. Une valeur absente ne signifie pas conforme ; une valeur inférieure à un seuil n’est pas zéro.
Research Information
GLOW50 provides a defined 35:10:5 mg per-vial formulation of GHK-Cu, TB-500 and BPC-157. Relevant ingredient literature covers fibroblast matrix synthesis, preclinical tendon biology and analytical identification of material described as TB-500. These distinct evidence streams provide research context rather than proof of activity for the combined formulation.
GLOW50 (GHK-Cu + TB-500 + BPC-157) Research & Studies
Composition and presentation
Each vial contains GHK-Cu 35 mg, TB-500 10 mg and BPC-157 5 mg, totaling 50 mg of labeled components. Packaging is 10 vials per box. The mass listing describes formulation content rather than an experimental concentration or use regimen.
GHK-Cu research context
GHK-Cu is a copper-complexed tripeptide investigated for matrix-associated cellular responses. Primary studies examined collagen synthesis and glycosaminoglycan production in fibroblast cultures. These findings are appropriate background for laboratory studies, without demonstrating a cosmetic or clinical outcome for GLOW50.
BPC-157 research context
BPC-157 is a synthetic pentadecapeptide studied in rat tendon models and cultured tendon cells. Reported endpoints include tendon-cell growth and growth-hormone-receptor expression. Such preclinical findings should remain linked to the individual compound and experimental model.
Interpreting TB-500 references
Analytical research identified the N-acetylated thymosin beta-4 fragment Ac-LKKTETQ in one TB-500 preparation. This catalog name alone does not verify the sequence of the supplied ingredient. Match product-specific analytical identity to each paper before using fragment or full-length thymosin beta-4 findings as research background.
Distinction from BBG50 and evidence limits
GLOW50 contains 35 mg GHK-Cu and 5 mg BPC-157 per vial, compared with 50 mg and 10 mg in BBG50; both list 10 mg TB-500. GLOW50 therefore totals 50 mg, while BBG50 totals 70 mg. The cited ingredient studies do not establish equivalent responses, superior performance or synergy for either blend.
Frequently Asked Questions
What is in each GLOW50 vial?
GHK-Cu 35 mg, TB-500 10 mg and BPC-157 5 mg, totaling 50 mg. Each box contains 10 vials.
Is GLOW50 interchangeable with BBG50 in research?
They have different component amounts and should not be treated as identical formulations. Any comparison needs to account for the concentration and verified identity of each component.
Does the GLOW name establish a skin benefit?
No. It is a catalog name. The referenced fibroblast studies provide ingredient-level research context and do not establish a skin or cosmetic outcome for this blend.
What is the intended research scope?
Laboratory characterization and exploratory studies informed by the individual ingredients' literature. The product is for research only, not human or veterinary use.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.